News

Stock Price Predictions: Analysts Share Insights on ZM and More

Stock Price Predictions: Analysts Share Insights on ZM and More

Analyst Stock Price Predictions

Wall Street analysts have provided fresh insights into several prominent stocks, reflecting updates and forecasts that could impact investors' decisions. Below, we delve into some key stocks and the changes made to their price targets alongside the respective analyst ratings.

RealReal Inc - Upgraded Outlook

Price Target Raised

RealReal Inc (NASDAQ: REAL) has seen its price target uplifted from $8 to $13, advised by Baird analyst Mark Altschwager. Maintaining a Neutral rating, the stock closed at $11.21 recently, showing positive movement amid growing confidence in the company's operations.

Tower Semiconductor Ltd - Positive Adjustment

Target Price Increased

Following a strong performance, Tower Semiconductor Ltd (NASDAQ: TSEM) received an upgrade from Susquehanna, raising the price target from $100 to $135. Analyst Medhi Hosseini holds a Positive rating, with Tower's shares closing at $98.10.

Oculis Holding AG - Maintaining Buy

Forecast for Growth

Oculis Holding AG (NASDAQ: OCS) saw its price target increase from $36 to $42, as stated by HC Wainwright & Co. Analyst Yi Chen has maintained a Buy rating, and shares settled at $19.42.

Bitdeer Technologies Group - Price Target Lifted

Analyst Confidence

Rosenblatt increased the price target for Bitdeer Technologies Group (NASDAQ: BTDR) from $20 to $30. Analyst Kevin Cassidy continues to hold a Buy rating, with Bitdeer’s shares closing at $17.65, highlighting a bullish outlook amidst market dynamics.

Neurocrine Biosciences Inc - Minor Adjustment

Price Target Cut Slightly

In contrast, Neurocrine Biosciences Inc (NASDAQ: NBIX) has had its price target reduced from $178 to $173 by Morgan Stanley. Analyst Jeffrey Hung maintains an Overweight rating, with the stock recently priced at $150.02, suggesting solid fundamentals despite the minor downgrade.

Zoom Communications Inc - Buy Rating Endorsed

Continued Confidence

Rosenblatt analyst Catharine Trebnick raised the price target for Zoom Communications Inc (NASDAQ: ZM) from $110 to $115, retaining a Buy rating. Zoom shares were priced at $83.16, indicating positive investor interest in its growth potential.

Appian Corp - Strong Upside

Upgraded Price Target

Morgan Stanley made a significant adjustment to Appian Corp (NASDAQ: APPN), increasing its price target from $29 to $45. With a current trading price of $42.31, the stock reflects a positive trend and strong growth expectations.

Monday.Com Ltd - Price Target Decrease

Neutral Rating Maintained

B of A Securities has cut the price target for Monday.Com Ltd (NASDAQ: MNDY) from $205 to $195, with analyst Michael Funk maintaining a Neutral rating. The stock was last seen at $166.21.

Skyworks Solutions Inc - Positive Outlook

Target Price Increased

Mizuho has raised the price target for Skyworks Solutions Inc (NASDAQ: SWKS) from $65 to $73, upgrading its rating from Underperform to Neutral. The shares closed at $69.10, indicating market optimism.

Bullish - Price Adjustment

Minor Cut in Target

Clear Street revised the price target for Bullish (NYSE: BLSH) down from $60 to $57. However, Clear Street analyst Owen Lau upgraded the stock from Hold to Buy, suggesting confidence remains strong, closing at $46.59.

Conclusion

These analyst insights provide a snapshot of the current sentiment surrounding various stocks, highlighting the continuous evolution of market expectations. Keeping track of analyst recommendations can be instrumental in making informed investment decisions, ensuring that one stays ahead of market trends.

Frequently Asked Questions

What are the key insights from the latest analyst forecasts?

Analysts have updated price targets for various stocks, indicating potential market movements and investor sentiment.

Which stocks have received the most significant upgrades?

RealReal Inc, Tower Semiconductor Ltd, and Zoom Communications Inc saw notable increases in their price targets, reflecting positive investor outlooks.

Are there any stocks that faced downgrades?

Yes, Neurocrine Biosciences Inc and Monday.Com Ltd had their price targets cut, albeit with varying analyst ratings still indicating potential.

What should investors look for in analyst ratings?

Investors should consider the reasons behind upgrades or downgrades and the analysts' ratings for a comprehensive view.

Why is understanding analyst forecasts important?

Understanding these forecasts can help investors make informed decisions based on market trends and company performance indicators.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 244

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 385

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 430

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Comercial Português Highlights Positive Share Buy-Back Activities

Updated Category News Views 137

Banco Comercial Português: An Overview of Recent Developments Banco Comercial Português, S.A., recognized for its pivotal role in the financial sector, has recently shared insights about its Share Buy-Back Programme. This initiative reflects the bank's commitment to enhancing shareholder value while solidifying its market presence. The interim report detailing the...

Continue Reading
How a $1000 Investment in Texas Instruments Transforms Over 15 Years

Updated Category News Views 135

Understanding the Growth of Texas Instruments Investments Texas Instruments (NASDAQ: TXN) has displayed impressive growth over the past 15 years, outpacing the market by an average of 2.3% annually. This translates to a robust average annual return of 14.17%, reflecting this company's strong position in the semiconductor industry. With a market capitalization now standing...

Continue Reading
Bitdeer Technologies Group's Q4 2024 Financial Overview

Updated Category News Views 204

Bitdeer Technologies Group's Financial Results Analysis Bitdeer Technologies Group (NASDAQ: BTDR), a prominent player in blockchain technology and high-performance computing, has recently unveiled its unaudited financial results for the final quarter of 2024. The announcement sheds light on the company's performance, revealing significant shifts in revenue and expenses...

Continue Reading
NodeAI Revolutionizes Lung Cancer Care with AI Solutions

Updated Category News Views 206

NodeAI's Groundbreaking Achievement in Cancer Diagnostics NodeAI, a pioneering startup based in Hamilton, Ontario, has recently garnered attention for its exceptional advancements in lung cancer diagnostics. The company participated in FACIT's annual pitch competition, known as Falcons' Fortunes, and emerged victorious, earning a prestigious award for its innovative...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 72

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading